Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Insights into diagnosis and treatment of rare pediatric brain cancer

Ependymoma is a rare form of brain cancer that implicates children and is often tricky to diagnose.

26 Mar 2020

Study contradicts theory that daily aspirin prevents dementia symptoms

Scientists have disproven the theory that taking a low dose of daily aspirin reduces cognitive symptoms of dementia.

25 Mar 2020

Novel imaging technique sheds light on Alzheimer's disease

To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.

25 Mar 2020

Researchers examine efficiency of non-invasive brain stimulation for memory improvement

A group of scientists from the Research Center of Neurology and Skoltech showed that human working memory can be tweaked using non-invasive magnetic stimulation of the brain. Also, they discovered that the effect of magnetic stimulation weakens as the brain works on a cognitive task under stimulation.

25 Mar 2020

Researchers identify novel blood-based markers to detect Alzheimer’s disease

In a recent study published in the Journal of Alzheimer’s Disease, researchers at Okayama University developed a technique to uncover molecules within the blood which can help doctors differentiate patients with Alzheimer’s disease from healthy individuals.

24 Mar 2020

Study uncovers a new childhood-onset neurodegenerative disorder

A study has uncovered a new neurodegenerative disorder in which children experience developmental regression and severe epilepsy.

21 Mar 2020

Researchers find key molecule that helps neurons maintain information in working memory

Working memory, the ability to hold a thought in mind even through distraction, is the foundation of abstract reasoning and a defining characteristic of the human brain.

19 Mar 2020

Viewpoint: Could infectious pathogens play a role in Alzheimer's disease?

For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.

18 Mar 2020

C-Path and Lundbeck join hands to improve scientific community's insight in Alzheimer's

The Critical Path Institute and H. Lundbeck A/S are proud to announce that they will work together to significantly improve the scientific community's insight in Alzheimer's disease through Lundbeck's contribution of a unique set of clinical trial data from more than 2,500 AD patients to the Critical Path for Alzheimer's Disease consortium's integrated database for qualified researchers across the globe to access.

18 Mar 2020

Immune mechanism in the brain appears to play key role in the development of Alzheimer's

An immune reaction in the brain seems to play a major role in the development of Alzheimer's disease. In a way, it "adds fuel to the fire" and apparently causes an inflammation that, in a sense, keeps kindling itself. The study has now been published in the journal Cell Reports.

18 Mar 2020

Novel Alzheimer's risk genes affect microglial response to amyloid-beta

Our DNA determines a large part of our risk for Alzheimer's disease, but it remained unclear how many genetic risk factors contribute to disease.

18 Mar 2020

Antioxidant treatment in acute ischemic stroke could delay onset of clinically overt dementia

Currently we are facing a dementia epidemic, with estimations showing that by 2050 approximately 131 million people will be affected.

17 Mar 2020

Technology effectively detects harsh side effect of breast cancer treatment

Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.

16 Mar 2020

Alzheimer's and its helper protein

It is commonly observed that the brain in patients with Alzheimer's disease (AD) often contains fibrils of tau protein, which build up within the brain neurons to interrupt proper communication between them. However, it is far from clear what these deposits mean and how they form.

15 Mar 2020

Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

Individuals with Down syndrome are at a much greater risk of developing Alzheimer's disease, with inflammation of the brain starting early in life and the risk of Alzheimer's reaching nearly 80% by the age of 60.

13 Mar 2020

NCAM2 protein is a vital factor in the formation of cerebral cortex, neuronal morphogenesis

The molecule NCAM2, a glycoprotein from the superfamily of immunoglobulins, is a vital factor in the formation of the cerebral cortex, neuronal morphogenesis and formation of neuronal circuits in the brain, as stated in the new study published in the journal Cerebral Cortex.

13 Mar 2020

NTHU research team develops new treatment for Parkinson’s disease

Ultrasound is widely used for conducting physical examinations, and plans are underway for expanding its application to the treatment of Parkinson's disease, dementia, and diabetes.

12 Mar 2020

No evidence of a link between surgery with anesthesia and Alzheimer's disease

Older adults who have surgery with general anesthesia may experience a modest acceleration of cognitive decline, even years later. But there's no evidence of a link to Alzheimer's disease, according to new research from Mayo Clinic.

12 Mar 2020

BIN1 deficit leads to impaired spatial learning and memory

Bridging integrator 1, known as BIN1, is the second most common risk factor for late-onset Alzheimer's disease, according to genome-wide studies of genetic variants. Yet, scientists know little about what this protein does in the brain.

11 Mar 2020

New approach to stimulate immune cells may provide better protection against Alzheimer's

Scientists at the German Center for Neurodegenerative Diseases, the Ludwig-Maximilians-Universitaet Munich and Denali Therapeutics (South San Francisco, CA, USA) have developed an approach to stimulate immune cells of the brain in such a way that they might possibly provide better protection against Alzheimer's disease.

10 Mar 2020

Alzheimer's Disease News and Research

Further Reading

Insights into diagnosis and treatment of rare pediatric brain cancer

Study contradicts theory that daily aspirin prevents dementia symptoms

Novel imaging technique sheds light on Alzheimer's disease

Researchers examine efficiency of non-invasive brain stimulation for memory improvement

Researchers identify novel blood-based markers to detect Alzheimer’s disease

Study uncovers a new childhood-onset neurodegenerative disorder

Researchers find key molecule that helps neurons maintain information in working memory

Viewpoint: Could infectious pathogens play a role in Alzheimer's disease?

C-Path and Lundbeck join hands to improve scientific community's insight in Alzheimer's

Immune mechanism in the brain appears to play key role in the development of Alzheimer's

Novel Alzheimer's risk genes affect microglial response to amyloid-beta

Antioxidant treatment in acute ischemic stroke could delay onset of clinically overt dementia

Technology effectively detects harsh side effect of breast cancer treatment

Alzheimer's and its helper protein

Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

NCAM2 protein is a vital factor in the formation of cerebral cortex, neuronal morphogenesis

NTHU research team develops new treatment for Parkinson’s disease

No evidence of a link between surgery with anesthesia and Alzheimer's disease

BIN1 deficit leads to impaired spatial learning and memory

New approach to stimulate immune cells may provide better protection against Alzheimer's

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News